XML 40 R45.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Available-for-sale Securities and Fair Value on Financial Instruments - Additional Information (Detail) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Schedule Of Available For Sale Securities [Line Items]      
Available-for-sale securities in unrealized net loss position $ 0 $ 283,000  
Other-than-temporary impairment losses $ 0 $ 0 $ 0
Remaining investment in common stock 144,291,000 136,853,000  
Gross realized losses from the sale or maturity of available-for-sale investments $ 0 $ 0 0
Aduro Biotech Inc      
Schedule Of Available For Sale Securities [Line Items]      
Gross realized gains from the sale of available-for-sale investments $ 0 $ 0 $ 3,500,000
Sale of common stock available-for-sale investments 0 0 346,700
Remaining investment in common stock 0 0